On April 25th 2017, MatriTek revealed its new name: East River BioSolutions.
The broader, more encompassing name better captures the company’s vision of revolutionizing the biomedical research and regenerative medicine markets.
“We have an exceptional track record of engineering and scientific excellence and are at the forefront of unlocking the power of native tissue matrix to develop innovative solutions to serve the life sciences industry. Going forward as East River BioSolutions, we will leverage that expertise to provide a wider range of cutting edge products,” commented Andrea Nye, CEO of East River BioSolutions.
East River BioSolutions will continue to strengthen its leading portfolio of tissue-specific extracellular matrices, complementing it with new offerings such as tissue-specific bio-inks and expanding application of its technologies in the growing therapeutic and biomedical markets.